EDIT vs FAST
Editas Medicine Inc (EDIT) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
EDIT currently screens at market cap $375.2M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the EDIT and FAST stock pages for the full models.
Not investment advice.